Advanced Therapy Medicinal Products CDMO Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1067444
  • December 2021
  • Healthcare
  • 144 Pages
Report Description

This report is a comprehensive study that examines the Advanced Therapy Medicinal Products CDMO industry in depth. With reference to key regions and major nations, the study specifies the product type of Advanced Therapy Medicinal Products CDMO as well as its use in various industrial verticals. Furthermore, the report identified and analysed all of the top companies functioning in the global Advanced Therapy Medicinal Products CDMO market arena, comparing and contrasting them based on market revenue, yearly sales volume, historical growth rate, and company strategies. The worldwide Advanced Therapy Medicinal Products CDMO market research offers a business strategy for current market participants to strengthen their market positions based on all of these findings. Furthermore, the paper recommends a market entry strategy for newcomers to the sector.

The top vendors and distributors operating in all of the major regions have also been highlighted in the Advanced Therapy Medicinal Products CDMO market report. This data and research should aid market players in strengthening their market distribution networks and expanding their geographic reach.
 
Advanced Therapy Medicinal Products CDMO Market Strategic Analysis 

The market was studied using several marketing methodologies such as Porter's Five Forces Analysis, player positioning analysis, SWOT analysis, market share analysis, and value chain analysis in the Advanced Therapy Medicinal Products CDMO market study. The market dynamics and factors such as the threat of a Advanced Therapy Medicinal Products CDMO substitute, the threat of new entrants into the Advanced Therapy Medicinal Products CDMO market, buyer bargaining power, supplier bargaining power to Advanced Therapy Medicinal Products CDMO providing companies, and internal rivalry among Advanced Therapy Medicinal Products CDMO providers are analysed in Porter's Five Forces analysis to provide the report's readers with a detailed view of the current market dynamics.

This analysis assists report users in evaluating the Advanced Therapy Medicinal Products CDMO market based on various parameters such as economies of scale, switching costs, brand loyalty, existing distribution channels, capital investments, manufacturing rights & patents, government regulations, advertising impact, and consumer preference impact. This simplified data is expected to aid the industry's key decision-makers in their decision-making process. Furthermore, this study answers the crucial question of whether or not new entrants should enter the Advanced Therapy Medicinal Products CDMO industry.
 
Advanced Therapy Medicinal Products CDMO Market Key Trends Analysis

The important factors influencing the growth of the Advanced Therapy Medicinal Products CDMO market have been examined in this report. The driving factors that are boosting demand for Advanced Therapy Medicinal Products CDMOs and the restraining factors that are slowing growth of the Advanced Therapy Medicinal Products CDMO industry are addressed in depth, as well as their implications for the worldwide Advanced Therapy Medicinal Products CDMO market. In addition, the published analysis identifies and discusses in detail the trends that are driving the market and impacting its growth. In addition, other qualitative variables such as risks connected with operations and key problems faced by market players are covered in the report.

Advanced Therapy Medicinal Products CDMO Market Key Segment Analysis

By segmenting the market by product type, application, and geography, the study provides a clear picture of the Advanced Therapy Medicinal Products CDMO industry. On the basis of current and future trends, all segments of the Advanced Therapy Medicinal Products CDMO industry have been examined. The market and its divisions are forecasted for the years 2021 through 2028. The study identifies the categories that are contributing the most to total market revenue growth, as well as the factors that are supporting their growth.

The research will provide a detailed qualitative and quantitative product type segment analysis for the years 2021 to 2028.

The report study analyses and includes a variety of prospective prospects and aspects affecting various applications.
 
Advanced Therapy Medicinal Products CDMO Market Regional Trends and Market Player’s Analysis

North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are the regions in which the market is divided. In 2020, the worldwide Advanced Therapy Medicinal Products CDMO market was dominated by North America. The Asia Pacific region is expected to have the highest CAGR for the Advanced Therapy Medicinal Products CDMO market throughout the projected period.


 
The market revenue, market shares, business strategies, recent developments, and growth rates of major players with substantial market shares in the global Advanced Therapy Medicinal Products CDMO market are all examined. These firms' recent developments, such as new solution/product launches, research projects, acquisitions, geographic expansions, and technological advancements, are taken into account when determining their position in the Advanced Therapy Medicinal Products CDMO market. All important stakeholders in the Advanced Therapy Medicinal Products CDMO value chain and technological ecosystem are expected to benefit from the insights offered in the Advanced Therapy Medicinal Products CDMO market research study.

In order to provide a broader understanding of the top competitors in the Advanced Therapy Medicinal Products CDMO market, the research includes a company market share analysis. Celonic, Bio Elpida, CGT Catapult, Rentschler Biopharma SE, AGC Biologics, Catalent, Lonza, WuXi Advanced Therapies, BlueReg, Minaris Regenerative Medicine, Patheon are among the major participants in the global Advanced Therapy Medicinal Products CDMO industry.
 
Scope of the report
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2021
Forecast Period Covered 2021-2028
Units for value Revenue in USD million and CAGR from 2021 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Companies Covered Celonic, Bio Elpida, CGT Catapult, Rentschler Biopharma SE, AGC Biologics, Catalent, Lonza, WuXi Advanced Therapies, BlueReg, Minaris Regenerative Medicine, Patheon
 
Major Highlights of the Advanced Therapy Medicinal Products CDMO Market report study:
  • An in-depth examination of the global Advanced Therapy Medicinal Products CDMO industry will be published soon.
  • The study examines the global Advanced Therapy Medicinal Products CDMO market and offers major actionable information to its players.
  • The research has taken into account all key events in the recent past, providing users with up-to-date industry information.
  • The report study is expected to aid the industry's key decision-makers in their decision-making process.
  • Data on market intelligence, changing market dynamics, existing and predicted market trends, and so on are included in the report.
  • The research includes a detailed examination of the macroeconomic and microeconomic aspects that influence the global Advanced Therapy Medicinal Products CDMO industry.
  • The Market Ecosystem and Adoption in Different Markets
  • The global Advanced Therapy Medicinal Products CDMO market is being shaped by several major trends.
  • The size of the Advanced Therapy Medicinal Products CDMO market in terms of revenue has been measured in the past and will be measured in the future in USD million.
  • Consumer preference patterns and recent industrial developments
  • The worldwide Advanced Therapy Medicinal Products CDMO market's competitive landscape and player positioning analysis
  • Major players' key goods and solutions, as well as their business strategies
  • Recommendations for new market entrants as well as existing market participants.
  • The study of niche and potential segments (product type, application, and regions/countries) predicts that promising growth will be noticed.
  • Operating players in the market encounter a number of significant hurdles.
  • An examination of the major risks involved in market operations
 
The report segment of the global Advanced Therapy Medicinal Products CDMO market as follows:
Global Advanced Therapy Medicinal Products CDMO Market: By Product Type

  • Gene Therapy
  • Cell Therapy
  • Tissue Engineered

Global Advanced Therapy Medicinal Products CDMO Market: By Application
  • Application I
  • Application II
  • Application III

Global Advanced Therapy Medicinal Products CDMO Market: By Region
  • North America
    • U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China 
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

The report study is drafted to provide actionable insights to the following mentioned audience:
  • Institutes of research and consulting firms
  • Companies are attempting to get into the Advanced Therapy Medicinal Products CDMO market.
  • Universities and students
  • Other companies in the Advanced Therapy Medicinal Products CDMO market include solution providers, product producers, service providers, and others.
  • Private companies and government agencies that are linked
  • Individuals interested in learning more about the Advanced Therapy Medicinal Products CDMO market

Manufacturers and Segments

  • Celonic
  • Bio Elpida
  • CGT Catapult
  • Rentschler Biopharma SE
  • AGC Biologics
  • Catalent
  • Lonza
  • WuXi Advanced Therapies
  • BlueReg
  • Minaris Regenerative Medicine
  • Patheon
  • Gene Therapy
  • Cell Therapy
  • Tissue Engineered
  • Application I
  • Application II
  • Application III

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Advanced Therapy Medicinal Products CDMO Market Snapshot
          2.1.1. Global Advanced Therapy Medicinal Products CDMO Market By Gene Therapy,2019
               2.1.1.1.
               2.1.1.2.Gene Therapy
               2.1.1.3.Cell Therapy
          2.1.2. Global Advanced Therapy Medicinal Products CDMO Market By Application I,2019
               2.1.2.1.
               2.1.2.2.Application I I
               2.1.2.3.Application I II
          2.1.3. Global Advanced Therapy Medicinal Products CDMO Market By End-use,2019
          2.1.4. Global Advanced Therapy Medicinal Products CDMO Market By Geography,2019

3. Global Advanced Therapy Medicinal Products CDMO Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Gene Therapy, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Gene Therapy, 2020
     4.2. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028

5. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application I, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application I, 2020
     5.2. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028

6. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028

7. Global Advanced Therapy Medicinal Products CDMO Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Advanced Therapy Medicinal Products CDMO Market Analysis, 2018 – 2028 
          7.2.1. North America Advanced Therapy Medicinal Products CDMO Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028
          7.2.3. North America Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028
          7.2.4. North America Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Advanced Therapy Medicinal Products CDMO Market Analysis, 2018 – 2028 
          7.3.1.  Europe Advanced Therapy Medicinal Products CDMO Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028
          7.3.3. Europe Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028
          7.3.4. Europe Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Advanced Therapy Medicinal Products CDMO Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Advanced Therapy Medicinal Products CDMO Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028
          7.4.3. Asia Pacific Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028
          7.4.4. Asia Pacific Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Advanced Therapy Medicinal Products CDMO Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Advanced Therapy Medicinal Products CDMO Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028
          7.5.3. Latin America Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028
          7.5.4. Latin America Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Advanced Therapy Medicinal Products CDMO Market Analysis, 2018 – 2028 
          7.6.1.  MEA Advanced Therapy Medicinal Products CDMO Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Advanced Therapy Medicinal Products CDMO Market Size (US$), By Gene Therapy, 2018 – 2028
          7.6.3. MEA Advanced Therapy Medicinal Products CDMO Market Size (US$), By Application I, 2018 – 2028
          7.6.4. MEA Advanced Therapy Medicinal Products CDMO Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Advanced Therapy Medicinal Products CDMO Providers
        8.4.1 Celonic
                8.4.1.1 Business Description
                8.4.1.2 Celonic Geographic Operations
                8.4.1.3 Celonic Financial Information
                8.4.1.4 Celonic Product Positions/Portfolio
                8.4.1.5 Celonic Key Developments
        8.4.2 Bio Elpida
                8.4.2.1 Business Description
                8.4.2.2 Bio Elpida Geographic Operations
                8.4.2.3 Bio Elpida Financial Information
                8.4.2.4 Bio Elpida Product Positions/Portfolio
                8.4.2.5 Bio Elpida Key Developments
        8.4.3 CGT Catapult
                8.4.3.1 Business Description
                8.4.3.2 CGT Catapult Geographic Operations
                8.4.3.3 CGT Catapult Financial Information
                8.4.3.4 CGT Catapult Product Positions/Portfolio
                8.4.3.5 CGT Catapult Key Developments
        8.4.4 Rentschler Biopharma SE
                8.4.4.1 Business Description
                8.4.4.2 Rentschler Biopharma SE Geographic Operations
                8.4.4.3 Rentschler Biopharma SE Financial Information
                8.4.4.4 Rentschler Biopharma SE Product Positions/Portfolio
                8.4.4.5 Rentschler Biopharma SE Key Developments
        8.4.5 AGC Biologics
                8.4.5.1 Business Description
                8.4.5.2 AGC Biologics Geographic Operations
                8.4.5.3 AGC Biologics Financial Information
                8.4.5.4 AGC Biologics Product Positions/Portfolio
                8.4.5.5 AGC Biologics Key Developments
        8.4.6 Catalent
                8.4.6.1 Business Description
                8.4.6.2 Catalent Geographic Operations
                8.4.6.3 Catalent Financial Information
                8.4.6.4 Catalent Product Positions/Portfolio
                8.4.6.5 Catalent Key Developments
        8.4.7 Lonza
                8.4.7.1 Business Description
                8.4.7.2 Lonza Geographic Operations
                8.4.7.3 Lonza Financial Information
                8.4.7.4 Lonza Product Positions/Portfolio
                8.4.7.5 Lonza Key Developments
        8.4.8 WuXi Advanced Therapies
                8.4.8.1 Business Description
                8.4.8.2 WuXi Advanced Therapies Geographic Operations
                8.4.8.3 WuXi Advanced Therapies Financial Information
                8.4.8.4 WuXi Advanced Therapies Product Positions/Portfolio
                8.4.8.5 WuXi Advanced Therapies Key Developments
        8.4.9 BlueReg
                8.4.9.1 Business Description
                8.4.9.2 BlueReg Geographic Operations
                8.4.9.3 BlueReg Financial Information
                8.4.9.4 BlueReg Product Positions/Portfolio
                8.4.9.5 BlueReg Key Developments
        8.4.10 Minaris Regenerative Medicine
                8.4.10.1 Business Description
                8.4.10.2 Minaris Regenerative Medicine Geographic Operations
                8.4.10.3 Minaris Regenerative Medicine Financial Information
                8.4.10.4 Minaris Regenerative Medicine Product Positions/Portfolio
                8.4.10.5 Minaris Regenerative Medicine Key Developments
        8.4.11 Patheon
                8.4.11.1 Business Description
                8.4.11.2 Patheon Geographic Operations
                8.4.11.3 Patheon Financial Information
                8.4.11.4 Patheon Product Positions/Portfolio
                8.4.11.5 Patheon Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Advanced Therapy Medicinal Products CDMO Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Advanced Therapy Medicinal Products CDMO Market Revenue, By Gene Therapy, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Advanced Therapy Medicinal Products CDMO Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Advanced Therapy Medicinal Products CDMO Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Advanced Therapy Medicinal Products CDMO Market Revenue, By Gene Therapy, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Advanced Therapy Medicinal Products CDMO Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Advanced Therapy Medicinal Products CDMO Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue, By Gene Therapy, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Advanced Therapy Medicinal Products CDMO Market Revenue, By Gene Therapy, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Advanced Therapy Medicinal Products CDMO Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Advanced Therapy Medicinal Products CDMO Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Advanced Therapy Medicinal Products CDMO Market Revenue, By Gene Therapy, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Advanced Therapy Medicinal Products CDMO Market Revenue, By Application I, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Advanced Therapy Medicinal Products CDMO Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Advanced Therapy Medicinal Products CDMO: Market Segmentation 
FIG. 2 Global Advanced Therapy Medicinal Products CDMO Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Advanced Therapy Medicinal Products CDMO Market, By Gene Therapy, 2019 (US$ Mn) 
FIG. 5 Global Advanced Therapy Medicinal Products CDMO Market, By Application I, 2019 (US$ Mn) 
FIG. 6 Global Advanced Therapy Medicinal Products CDMO Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Advanced Therapy Medicinal Products CDMO Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Advanced Therapy Medicinal Products CDMO Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Advanced Therapy Medicinal Products CDMO Providers, 2019
FIG. 11 Global Advanced Therapy Medicinal Products CDMO Market Revenue Contribution, By Gene Therapy, 2019 & 2028 (Value %) 
FIG. 12 Global Advanced Therapy Medicinal Products CDMO Market Revenue Contribution, By Application I, 2019 & 2028 (Value %) 
FIG. 13 Global Advanced Therapy Medicinal Products CDMO Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Advanced Therapy Medicinal Products CDMO Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Advanced Therapy Medicinal Products CDMO Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Advanced Therapy Medicinal Products CDMO Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Advanced Therapy Medicinal Products CDMO Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Advanced Therapy Medicinal Products CDMO Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Advanced Therapy Medicinal Products CDMO market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Advanced Therapy Medicinal Products CDMO Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Advanced Therapy Medicinal Products CDMO Market Value, By Segment1, 2018 – 2028
TABLE  North America Advanced Therapy Medicinal Products CDMO Market Value, By Segment2, 2018 – 2028
TABLE  North America Advanced Therapy Medicinal Products CDMO Market Value, By Country, 2018 – 2028
TABLE  Europe Advanced Therapy Medicinal Products CDMO Market Value, By Segment1, 2018 – 2028
TABLE  Europe Advanced Therapy Medicinal Products CDMO Market Value, By Segment2, 2018 – 2028
TABLE  Europe Advanced Therapy Medicinal Products CDMO Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Advanced Therapy Medicinal Products CDMO Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Advanced Therapy Medicinal Products CDMO Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Advanced Therapy Medicinal Products CDMO Market Value, By Country, 2018 – 2028
TABLE  Latin America Advanced Therapy Medicinal Products CDMO Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Advanced Therapy Medicinal Products CDMO Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Advanced Therapy Medicinal Products CDMO Market Value, By Country, 2018 – 2028
TABLE  MEA Advanced Therapy Medicinal Products CDMO Market Value, By Segment1, 2018 – 2028
TABLE  MEA Advanced Therapy Medicinal Products CDMO Market Value, By Segment2, 2018 – 2028
TABLE  MEA Advanced Therapy Medicinal Products CDMO Market Value, By Country, 2018 – 2028
TABLE  Celonic: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio Elpida: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  CGT Catapult: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Rentschler Biopharma SE: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  AGC Biologics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Catalent: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Lonza: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  WuXi Advanced Therapies: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  BlueReg: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Minaris Regenerative Medicine: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Patheon: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Advanced Therapy Medicinal Products CDMO Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Advanced Therapy Medicinal Products CDMO Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Advanced Therapy Medicinal Products CDMO Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Advanced Therapy Medicinal Products CDMO Market, By Geography, 2019 (US$ Mn)
FIG.  Global Advanced Therapy Medicinal Products CDMO Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Advanced Therapy Medicinal Products CDMO Providers, 2016
FIG.  Global Advanced Therapy Medicinal Products CDMO Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Gene Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Cell Therapy Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Tissue Engineered Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Advanced Therapy Medicinal Products CDMO Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Application I Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application II Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Application III Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Advanced Therapy Medicinal Products CDMO Market Value, 2018 – 2028, (US$ Mn)